18 September 2019 in Life Science Alliance
The universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on α-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson’s disease. Here, we demonstrate that polyP is unable to accelerate the rate-limiting step of α-synuclein fibril formation but effectively nucleates fibril assembly once α-synuclein oligomers are formed. Binding of polyP to α-synuclein either during fibril formation or upon fibril maturation substantially alters fibril morphology and effectively reduces the ability of α-synuclein fibrils to interact with cell membranes. The effect of polyP appears to be α-synuclein fibril specific and successfully prevents the uptake of fibrils into neuronal cells. These results suggest that altering the polyP levels in the extracellular space might be a potential therapeutic strategy to prevent the spreading of the disease.
16 May 2023 in ChemBioChem
Photodynamic therapy (PDT) is a photochemistry‐based medical treatment combining light at a specific wavelength and a photosensitizer (PS) in the presence of oxygen. Application of PDT as a conventional treatment is limited and clearly the approval in clinics of new PS is challenging. The selective accumulation of the PS in the targeted malignant cells is of paramount importance to reduce the side effects that are typical of the current worldwide approved PS. Here we report a new series of aniline‐ and iodine‐substituted BODIPY derivatives (1–3) as promising lysosome‐targeting and pH‐responsive theranostic PS, which displayed a significant in vitro light‐induced cytotoxicity, efficient imaging properties and low dark toxicity (for 2 and 3). These compounds were obtained in few reproducible synthetic steps and good yields. Spectroscopic and electrochemical measurements along with computational calculations confirmed the quenching of the emissive properties of the PS, while both fluorescence and 1O2 emission were obtained only under acidic conditions inducing amine protonation. The pKa values and pH‐dependent emissive properties of 1–3 being established, their cellular uptake and activation in the lysosomal vesicles (pH≈4‐5) were confirmed by their co‐localization with the commercial LysoTracker deep red and light‐induced cytotoxicity (IC50 between 0.16 and 0.06 μM) against HeLa cancer cells.
1 July 2012 in Tetrahedron Letters
28 November 2025 in bioRxiv
Micro-satellite repeat expansion of the 5’ GGGGCC 3’ sequence in the C9orf72 gene is the most common monogenic form of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dipeptide repeat proteins (DPRs) translated from the mutant allele can be detected in postmortem brains of afflicted individuals. The arginine containing peptides, poly-PR and poly-GR, are particularly noxious to cells. Both have been shown to undergo cell-cell transmission, but the underlying mechanisms are not understood. We found rapid internalization and nucleolar localization of bath-applied hemagglutinin (HA) tagged poly-PR with twenty repeats (HA-PR 20 ) in cell lines and neurons. Small molecule and RNAi approaches implicated a temperature-dependent, fluid phase endocytosis mechanism in HA-PR 20 uptake. We sought to identify DPR-related cell surface uptake factors using a high-resolution proximity labeling technique developed in the MacMillan group, termed µMap. DPR-iridium conjugates identified candidate cell-surface proteins which were interrogated in an RNAi screen. Focusing on our strongest candidate, chondroitin sulfate proteoglycan 4 (CSPG4), we showed that cellular uptake of HA-PR 20 is blocked by inhibition of glycosaminoglycan chain synthesis (using drugs or RNAi) and knockdown or ablation of CSPG4 (using RNAi or CRISPR editing). Reduction of CSPG4 protected PR 20 -induced neuronal toxicity. We used a dual reporter system to interrogate in vitro neuron-to-neuron transmission of PR 50 and found that PR 50 synthesized by one neuron readily spread to neighboring neurons. Transmission was significantly reduced when CSPG4 was knocked down. These results suggest CSPG4 is an important factor in poly-PR internalization and transmission and therefore may be a therapeutic target to slow DPR transmission and disease progression. Significance Statement: A GGGGCC hexanucleotide repeat expansion in the C9orf72 gene is the most common monogenic form of ALS/FTD. This expansion leads to dipeptide repeat protein (DPR) production through non-canonical translation of repeat-containing RNA. DPRs have been shown to transmit between cells, but how this occurs is not well understood. We identified the cell surface protein chondroitin sulfate proteoglycan 4 (CSPG4) as a mediator of the uptake and intercellular spread of toxic arginine-rich DPRs. Targeting CSPG4 may provide a strategy to block DPR transmission and slow disease progression.
16 November 2026 in Proceedings of the National Academy of Sciences
Microsatellite repeat expansion of the 5′ GGGGCC 3′ sequence in the C9orf72 gene is the most common monogenic form of amyotrophic lateral sclerosis and frontotemporal dementia. Dipeptide repeat proteins (DPRs) translated from the mutant allele can be detected in postmortem brains of afflicted individuals. The arginine containing peptides, poly proline-arginine (poly-PR) and poly glycine-arginine (poly-GR), are particularly noxious to cells. Both can undergo cell-to-cell transmission, but underlying mechanisms are not understood. We found rapid internalization and nucleolar localization of bath-applied hemagglutinin (HA) tagged poly-PR with twenty repeats (HA-PR 20 ) in cell lines and neurons. Small molecule and RNAi approaches implicated a temperature-dependent, fluid phase endocytosis mechanism for HA-PR 20 . We sought to identify DPR-related cell surface uptake factors using µMap high-resolution proximity labeling. DPR–iridium conjugates identified candidate cell-surface proteins which were interrogated in a secondary RNAi screen. Focusing on our strongest candidate, chondroitin sulfate proteoglycan 4 (CSPG4), we showed cellular uptake of HA-PR 20 is reduced by inhibition of glycosaminoglycan chain synthesis and knockdown or ablation of CSPG4. Knockdown of CSPG4 protected PR 20 -induced neuronal toxicity. Using a dual reporter system to interrogate in vitro neuron-to-neuron transmission of PR 50, we found PR 50 synthesized by one neuron readily spread to neighboring cells. Transmission was significantly reduced with CSPG4 knockdown. Similarly conditioned media from PR 50 or GR 50 expressing neurons contained transmissible protein that was internalized into neurons in a CSPG4-dependent manner. These results suggest CSPG4 participates in poly-PR/poly-GR internalization and transmission.